QSAR and Molecular Docking Studies of Pyrimidine-Coumarin-Triazole Conjugates as Prospective Anti-Breast Cancer Agents

Cancer is a life-threatening disease and is the second leading cause of death worldwide. Although many drugs are available for the treatment of cancer, survival outcomes are very low. Hence, rapid development of newer anticancer agents is a prime focus of the medicinal chemistry community. Since the...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramani, Arun Kumar, Sivaperuman, Amuthalakshmi, Natarajan, Ramalakshmi, Bhandare, Richie R., Shaik, Afzal B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955476/
https://www.ncbi.nlm.nih.gov/pubmed/35335208
http://dx.doi.org/10.3390/molecules27061845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955476/
https://www.ncbi.nlm.nih.gov/pubmed/35335208
http://dx.doi.org/10.3390/molecules27061845

Ejemplares similares